Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Brainstorm Cell Therapeutics:收到纳斯达克的来信,表明截至4月29日,该公司尚未恢复遵守最低出价要求
Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Brainstorm Cell Therapeutics:收到纳斯达克的来信,表明截至4月29日,该公司尚未恢复遵守最低出价要求
使用浏览器的分享功能,分享给你的好友吧